The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Can clinical factors estimate insulin resistance in type 1 diabetes?
Open accessAbstract
An insulin resistance syndrome (IRS) score was developed based on clinical risk factors in adults with childhood-onset type 1 diabetes in the Epidemiology of Diabetes Complications (EDC) Study and was validated using euglycemic-hyperinsulinemic clamp studies. Hypertension, waist-to-hip ratio (WHR), triglyceride and HDL cholesterol levels, family history of type 2 diabetes, and glycemic control were risk factors used to define the score. A score of 1 (lowest likelihood IRS) to 3 (highest likelihood IRS) was assigned for each risk factor. Eligible subjects (n = 24) were recruited from the EDC cohort based on tertile of IRS score. Subjects received an overnight insulin infusion to normalize glucose levels, then underwent a 3-h euglycemic-hyperinsulinemic (60 mU x m(-2) x min(-1)) clamp. Glucose disposal rate (GDR) was determined during the last 30 min of the clamp. The GDR differed significantly by IRS group (9.65 +/- 2.99, 8.02 +/- 1.39, and 5.68 +/- 2.16 mg x kg(-1) x min(-1), P < 0.01). The GDR was inversely correlated with the IRS score (r = -0.64, P < 0.01). Using linear regression, the combination of risk factors that yielded the highest adjusted r2 value (0.57, P < 0.001) were WHR, hypertension, and HbA1. This study found that clinical risk factors can be used to identify subjects with type 1 diabetes who are insulin resistant, and it provides validation of a score based on clinical factors to determine the extent of insulin resistance in type 1 diabetes. This score will be applied to the entire EDC population in future studies to determine the effect of insulin resistance on complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In men with type 1 diabetes, cFT levels were also independently associated with eGDR, a marker of insulin sensitivity in individuals with type 1 diabetes (24), after adjusting for age (P ϭ 0.04).”
From Low testosterone levels are common and associated with insulin resistance in men with diabetes (2008) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Larsson, B., Svärdsudd, K., Welin, L., Wilhelmsen, L., Björntorp, P. A., & Tibblin, G. (1984) · BMJ · doi:10.1136/bmj.288.6428.1401 · Cited by 1,931
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
DeFronzo, R. A., Simonson, D. C., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 539
Insulin resistance in insulin-dependent diabetic patients with microalbuminuria
Yip, J. W., Mattock, M. B., Morocutti, A., Sethi, M., Trevisan, R., & Viberti, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91943-g · Cited by 244
Orchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Ellis, D., LaPorte, R. E., Kuller, L. H., Wolfson, S. K., & DRASH, A. L. (1990) · Diabetes Care · doi:10.2337/diacare.13.7.741 · Cited by 207
The role of insulin resistance and hyperinsulinemia in coronary heart disease
Reaven, G. M. (1992) · Metabolism · doi:10.1016/0026-0495(92)90088-r · Cited by 114
Insulin sensitivity and vascular disease in insulin-dependent diabetics.
Martin, F. I. R., & Stocks, A. E. (1968) · BMJ · doi:10.1136/bmj.2.5597.81 · Cited by 46
Martin, F. I. R., & Hopper, J. L. (1987) · Diabetologia · doi:10.1007/bf00274219 · Cited by 39
Cited by
Sorted by citations
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Grossmann, M., Thomas, M. C., Panagiotopoulos, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., & Jerums, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2177 · Cited by 468
Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2007) · Diabetes Care · doi:10.2337/dc06-1982 · Cited by 446
Metabolic Syndrome in Type 1 Diabetes
Thorn, L. M., Forsblom, C. M., Fagerudd, J. A., Thomas, M. C., Pettersson-Fernholm, K., Saraheimo, M., Wadén, J., Rönnback, M., Rosengård‐Bärlund, M., af Björkesten, C.-G., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2019 · Cited by 426
Hering, B. J., Kandaswamy, R., Harmon, J. V., Ansite, J. D., Clemmings, S. M., Sakai, T., Paraskevas, S., Eckman, P., Sageshima, J., Nakano, M., et al. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00351.x · Cited by 369
Orchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 317
Type 1 diabetes and coronary artery disease
Orchard, T. J., Costacou, T., Kretowski, A., & Nesto, R. W. (2006) · Diabetes Care · doi:10.2337/dc06-1161 · Cited by 305
Self-citationLow Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification
Maahs, D. M., Ogden, L. G., Kinney, G. L., Wadwa, P., Snell‐Bergeon, J. K., Dabelea, D., Hokanson, J. E., Ehrlich, J., Eckel, R. H., & Rewers, M. (2005) · Circulation · doi:10.1161/01.cir.0000155251.03724.a5 · Cited by 294
Recommendations for Management of Diabetes During Ramadan
Alarouj, M., Bouguerra, R., Buse, J. B., Hafez, S. S., Hassanein, M. M., Ibrahim, M. A., Ismail‐Beigi, F., El‐Kebbi, I. M., Khatib, O., Kishawi, S., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2305 · Cited by 290
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
Saraheimo, M., Teppo, A.-M., Forsblom, C., Fagerudd, J., & Groop, P.-H. (2003) · Diabetologia · doi:10.1007/s00125-003-1194-5 · Cited by 255
Dabelea, D., Kinney, G. L., Snell‐Bergeon, J. K., Hokanson, J. E., Eckel, R. H., Ehrlich, J., Garg, S. K., Hamman, R. F., & Rewers, M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2833 · Cited by 251
Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe
Soedamah‐Muthu, S. S., Chaturvedi, N., Toeller, M., Ferriss, B., Reboldi, G., Michel, G., Manes, C., Fuller, J., & the EURODIAB Prospective Complications Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.2.530 · Cited by 250
Orchard, T. J., Chang, Y.-F., Ferrell, R. E., Petro, N., & Ellis, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00507.x · Cited by 239
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
Cleland, S. J., Fisher, B. M., Colhoun, H. M., Sattar, N. A., & Petrie, J. R. (2013) · Diabetologia · doi:10.1007/s00125-013-2904-2 · Cited by 251
Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M. (2011) · Diabetes · doi:10.2337/db10-0328 · Cited by 230
Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes
Nyström, T., Holzmann, M. J., Eliasson, B., Svensson, A., & Sartipy, U. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13110 · Cited by 222
Epstein, E. J., Osman, J. L., Cohen, H. W., Rajpathak, S. N., Lewis, O., & Crandall, J. P. (2013) · Diabetes Care · doi:10.2337/dc12-1693 · Cited by 214
Risk Factors for Cardiovascular Disease in Type 1 Diabetes
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group (2016) · Diabetes · doi:10.2337/db15-1517 · Cited by 209
“5 channel blockers), lipid levels (total cholesterol, triglycerides, LDL and HDL cholesterol levels), diabetes specific (duration of diabetes, baseline stimulated C-peptide, daily insulin dose, estimated glucose disposal rate (12)), microvascular complications (estimated GFR, albumin excretion rate, presence of microa…”
BackgroundZabala, A., Darsalia, V., Lind, M., Svensson, A., Franzén, S., Eliasson, B., Patrone, C., Jonsson, M., & Nyström, T. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01394-4 · Cited by 201
Type 1 diabetes, metabolic syndrome and cardiovascular risk
Chillarón, J. J., Flores Le-Roux, J. A., Benaiges, D., & Pedro-Botet, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.002 · Cited by 195
Pambianco, G., Costacou, T., & Orchard, T. J. (2007) · Diabetes Care · doi:10.2337/dc06-2053 · Cited by 198
Self-citationCardiovascular Disease Risk Factors in Youth With Diabetes Mellitus
Maahs, D. M., Daniels, S. R., de Ferranti, S. D., Dichek, H. L., Flynn, J. T., Goldstein, B. I., Kelly, A. S., Nadeau, K. J., Martyn-Nemeth, P. A., Osganian, S. K., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000094 · Cited by 199
Obesity in people living with type 1 diabetes
der Schueren, B. V., Ellis, D., Faradji, R. N., Al‐Ozairi, E., Rosen, J., & Mathieu, C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00246-1 · Cited by 201
for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Penno, G., Solini, A., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Zerbini, G., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01936-3 · Cited by 173
Dabelea, D., Agostino, R. B. D., Mason, C. C., West, N., Hamman, R. F., Mayer‐Davis, E. J., Maahs, D. M., KLINGENSMITH, G. J., Knowler, W. C., & Nadeau, K. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1911-9 · Cited by 150
Puberty as an accelerator for diabetes complications
Cho, Y. H., Craig, M. E., & Donaghue, K. C. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12112 · Cited by 145
Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus
Bjornstad, P., Schäfer, M., Truong, U. T., Cree‐Green, M., Pyle, L., Baumgartner, A., Garcia‐Reyes, Y., Maniatis, A. K., Nayak, S., Wadwa, R. P., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035525 · Cited by 147
Chillarón, J. J., Goday, A., Roux, J. A. F., Benaiges, D., Carrera, M. J., de Dou, J. P., Cano-Pérez, J. F., & Pedro‐Botet, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0960 · Cited by 142
Type 2 diabetes mellitus and exercise impairment
Reusch, J. E. B., Bridenstine, M., & Regensteiner, J. G. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9234-4 · Cited by 142
Sviklāne, L., Olmane, E., Dzērve, Z., Kupčs, K., Pīrāgs, V., & Sokolovska, J. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13814 · Cited by 133
Insulin resistance in type 1 diabetes
Greenbaum, C. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.291 · Cited by 133
Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Saraheimo, M., Forsblom, C. M., Fagerudd, J. A., Teppo, A., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131
Tuomi, T. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s40 · Cited by 129
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
Espes, D., Lau, J., & Carlsson, P. (2013) · Diabetologia · doi:10.1007/s00125-013-3071-1 · Cited by 128
Khawandanah, J. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0101-1 · Cited by 131
Double diabetes: a distinct high-risk group?
Kietsiriroje, N., Pearson, S., Campbell, M., Ariëns, R. A. S., & Ajjan, R. A. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13848 · Cited by 123
Costacou, T., Zgibor, J. C., Evans, R. W., Otvos, J. D., Lopes-Virella, M. F., Tracy, R. P., & Orchard, T. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1597-y · Cited by 124
Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition
Bielka, W., Przezak, A., Molęda, P., Pius‐Sadowska, E., & Machaliński, B. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02145-x · Cited by 150
Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes
Zampetaki, A., Willeit, P., Burr, S., Yin, X., Langley, S. R., Kiechl, S. J., Klein, R., Rossing, P. R., Chaturvedi, N., & Mayr, M. (2015) · Diabetes · doi:10.2337/db15-0389 · Cited by 118
Prince, C. T., Becker, D. J., Costacou, T., Miller, R. G., & Orchard, T. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0797-7 · Cited by 119
Costacou, T., Ferrell, R. E., & Orchard, T. J. (2008) · Diabetes · doi:10.2337/db08-0095 · Cited by 118
Coexistence of type 1 and type 2 diabetes mellitus: “double” diabetes?
Libman, I. M., & Becker, D. J. (2003) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2003.00012.x · Cited by 112
Miller, R. G., Costacou, T., & Orchard, T. J. (2018) · Diabetes · doi:10.2337/db18-0515 · Cited by 112
Soedamah‐Muthu, S. S., Chang, Y., Otvos, J. D., Evans, R. G., & Orchard, T. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1094-8 · Cited by 111
Features of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell‐Bergeon, J. K., Eckel, R. H., Perreault, L., & Rewers, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3172 · Cited by 110
Olson, J. C., Erbey, J. R., Forrest, K. Y. Z., Williams, K. V., Becker, D. J., & Orchard, T. J. (2002) · Metabolism · doi:10.1053/meta.2002.30021 · Cited by 105
González‐Clemente, J. M., Mauricio, D., Richart, C., Broch, M., Caixàs, A., Megía, A., Giménez‐Palop, O., Simón, I., Martínez-Riquelme, A., Giménez‐Pérez, G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02376.x · Cited by 101
Garg, S. K., Moser, E. G., Bode, B. W., Klaff, L. J., Hiatt, W. R., Beatson, C. R., & Snell‐Bergeon, J. K. (2012) · Endocrine Practice · doi:10.4158/ep12100.or · Cited by 101
Saraheimo, M., Forsblom, C. M., Hansen, T. K., Teppo, A.-M., Fagerudd, J. A., Pettersson-Fernholm, K., Thiel, S., Tarnow, L., Ebeling, P. R., Flyvbjerg, A., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1594-1 · Cited by 97
Sun, R., Wang, J., Li, M., Li, J., Pan, Y., Liu, B., Lip, G. Y. H., & Zhang, L. (2024) · Diabetes Care · doi:10.2337/dc24-0475 · Cited by 100
Leisure Time Physical Activity Is Associated With Poor Glycemic Control in Type 1 Diabetic Women
Wadén, J., Tikkanen, H. O., Forsblom, C. M., Fagerudd, J. A., Pettersson-Fernholm, K., Lakka, T. A., Riska, M. K., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.4.777 · Cited by 94
Ren, X., Jiang, M., Han, L., & Zheng, X. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03689-x · Cited by 92
He, H., Xie, Y., Chen, Q., Li, Y., Li, X.-X., Mu, Y.-K., Duo, X., Gao, Y., & Zheng, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02396-8 · Cited by 93
Snell‐Bergeon, J. K., CHARTIER-LOGAN, C. J., Maahs, D. M., Ogden, L. G., Hokanson, J. E., Kinney, G. L., Eckel, R. H., Ehrlich, J., & Rewers, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1280-4 · Cited by 90
Insulin sensitivity in Type 1 diabetic children and adolescents
Szadkowska, A., Pietrzak, I., Mianowska, B., Bodalska-Lipińska, J., Keenan, H. A., Toporowska‐Kowalska, E., Mlynarski, W. M., & Bodalski, J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02357.x · Cited by 90
Uruska, A. A., Zozulińska‐Ziółkiewicz, D., Niedźwiecki, P., Pietrzak, M., & Wierusz‐Wysocka, B. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.005 · Cited by 85
The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
McGill, M. J., Molyneaux, L. M., Twigg, S. M., & Yue, D. K. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.005 · Cited by 85
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Šimonienė, D., Platūkienė, A., Prakapienė, E., Radzevičienė, L., & Veličkienė, D. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00729-5 · Cited by 83
Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir
Peterson, G. E. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x154178 · Cited by 80
Olson, J. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00269-1 · Cited by 81
Cardiovascular risk in double diabetes mellitus—when two worlds collide
Cleland, S. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.47 · Cited by 81
Exercise Training and Cardiovascular Risk Factors in Type 1 Diabetic Adolescent Girls
Heyman, E., Toutain, C., Delamarche, P., Berthon, P. M., Briard, D., Youssef, H. A., DeKerdanet, M., & Gratas‐Delamarche, A. (2007) · Pediatric Exercise Science · doi:10.1123/pes.19.4.408 · Cited by 81
Specht, B. J., Wadwa, R. P., Snell‐Bergeon, J. K., Nadeau, K. J., Bishop, F. K., & Maahs, D. M. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.07.036 · Cited by 77
Addressing insulin resistance in Type 1 diabetes
Pang, T. T. L., & Narendran, P. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02493.x · Cited by 81
Maahs, D. M., Ogden, L. G., Kretowski, A. J., Snell‐Bergeon, J. K., Kinney, G. L., Berl, T., & Rewers, M. (2007) · Diabetes · doi:10.2337/db07-0539 · Cited by 76
Jiang, L., Zhu, T., Song, W., Zhai, Y., Tang, Y. R., Ruan, F., Xu, Z., Li, L., Fu, X., Liu, D., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02618-7 · Cited by 77
Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease
Baršić, N. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i30.3945 · Cited by 76
Duca, L. M., Maahs, D. M., Schauer, I. E., Bergman, B. C., Nadeau, K. J., Bjornstad, P., Rewers, M., & Snell‐Bergeon, J. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3272 · Cited by 76
Socioeconomic Factors in the Development of Childhood Obesity and Diabetes
Lieb, D. C., Snow, R. E., & DeBoer, M. D. (2009) · Clinics in Sports Medicine · doi:10.1016/j.csm.2009.02.004 · Cited by 76
Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag
Larcher, S., Gauchez, A., Lablanche, S., Pépin, J., Benhamou, P., & Borel, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0188 · Cited by 72
Helliwell, R., Warnes, H., Kietsiriroje, N., Campbell, M. D., Birch, R. J., Pearson, S. M., & Ajjan, R. (2021) · Diabetic Medicine · doi:10.1111/dme.14529 · Cited by 73
The Effect of Metformin in Overweight Patients with Type 1 Diabetes and Poor Metabolic Control
Jacobsen, I. B., Henriksen, J. E., & Beck‐Nielsen, H. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00380.x · Cited by 69
Evidence for Heterogeneous Pathogenesis of Insulin-Treated Diabetes in Black and White Children
Libman, I. M., Pietropaolo, M., Arslanian, S. A., LaPorte, R. E., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2876 · Cited by 66
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule
Vergouwe, Y., Soedamah‐Muthu, S. S., Zgibor, J. C., Chaturvedi, N., Forsblom, C. M., Snell‐Bergeon, J. K., Maahs, D. M., Groop, P., Rewers, M., Orchard, T. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1585-3 · Cited by 69
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes
Klein, R. L., Hunter, S. J., Jenkins, A. J., Zheng, D., Semler, A. J., Clore, J., Garvey, W. T., & The DCCT/EDIC Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1439 · Cited by 69
Linn, W., Persson, M., Rathsman, B., Ludvigsson, J., Lind, M., Andersson, M., & Nyström, T. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01791-x · Cited by 72
Wołosowicz, M., Łukaszuk, B., & Chabowski, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228651 · Cited by 69
Insulin sensitivity and complications in type 1 diabetes: New insights
Bjornstad, P. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.8 · Cited by 66
Costacou, T., Ellis, D., Fried, L. F., & Orchard, T. J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.08.005 · Cited by 66
González‐Clemente, J. M., Vilardell, C. P., Broch, M., Megía, A., Caixàs, A., Giménez‐Palop, O., Richart, C., Simón, I., Martínez-Riquelme, A., Arroyo, J., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0090 · Cited by 66
Smoking and progression of diabetic nephropathy in patients with type 1 diabetes
Feodoroff, M., Harjutsalo, V., Forsblom, C. M., Thorn, L. M., Wadén, J., Tolonen, N., Lithovius, R., & Groop, P. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0822-0 · Cited by 64
Estimation of insulin sensitivity in children: methods, measures and controversies
Brown, R. J., & Yanovski, J. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12146 · Cited by 65
Bebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M., Lachin, J. M., & the DCCT/EDIC Research Group (2019) · Diabetes Care · doi:10.2337/dc18-1613 · Cited by 62
Self-citationMaahs, D. M., Hokanson, J. E., Wang, H., Kinney, G. L., Snell‐Bergeon, J. K., East, A., Bergman, B. C., Schauer, I. E., Rewers, M., & Eckel, R. H. (2010) · Diabetes · doi:10.2337/db09-1626 · Cited by 61
Pané, A., Conget, I., Boswell, L., Ruiz, S., Viñals, C., Perea, V., Giménez, M., Cofán, M., Blanco, J., Vinagre, I., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3323 · Cited by 60
At last, a weight neutral insulin?
Fritsche, A., & Häring, H.-U. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802749 · Cited by 59
Nyström, T., Holzmann, M. J., Eliasson, B., Svensson, A., Kuhl, J., & Sartipy, U. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0875-1 · Cited by 55
Chen, X., Li, A., & Ma, Q. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02599-7 · Cited by 53
Fortin, A., RABASA-LHORET, R. P. R., Lemieux, S., Labonté, M., & Gingras, V. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.08.005 · Cited by 52
Bojanin, D., Vekić, J., Milenković, T., Vuković, R., Zeljković, A., Stefanović, A., Janać, J., Ivanišević, J., Mitrović, K., Miljković, M., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.020 · Cited by 52
Greenfield, J. R., Samaras, K., & Chisholm, D. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8324 · Cited by 53
Costacou, T., Lopes-Virella, M. F., Zgibor, J. C., Virella, G., Otvos, J., Walsh, M., & Orchard, T. J. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.01.003 · Cited by 53
Different Risk Factor Profiles for Ischemic and Hemorrhagic Stroke in Type 1 Diabetes Mellitus
Hägg-Holmberg, S., Thorn, L. M., Forsblom, C. M., Gordin, D., Saraheimo, M., Tolonen, N., Wadén, J., Liebkind, R., Jukka Putaala, A., Tatlisumak, T., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.005724 · Cited by 52
Denic-Roberts, H., Costacou, T., & Orchard, T. J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.013 · Cited by 51
“Insulin sensitivity was determined by a previously validated estimated glucose disposal rate (eGDR) regression equation [36].”
MethodBergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell‐Bergeon, J. K., Clement, T. W., Eckel, R. H., Perreault, L., & Rewers, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2892 · Cited by 51
Progression of Coronary Artery Calcium in Type 1 Diabetes Mellitus
Costacou, T., Edmundowicz, D., Prince, C. T., Conway, B. N., & Orchard, T. J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.050 · Cited by 51
Metadata
- Authors
- Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J.
- Affiliations
- University of Pittsburgh (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2000-04-01
- Volume
- 49
- Issue
- 4
- Pages
- 626-632
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2143570364
- Cited by
- 640
- References
- 11
- Citations by year
- 2026: 66 · 2025: 94 · 2024: 47 · 2023: 42 · 2022: 38 · 2021: 39 · 2020: 27 · 2019: 15 · 2018: 26 · 2017: 16 · 2016: 17 · 2015: 23 · 2014: 22 · 2013: 25 · 2012: 16
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (2 T32 DK07052-22, T32DK007052)
- National Center for Research Resources (5M01-RRR00084)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- insulin resistance, type 1 diabetes, childhood-onset diabetes, clinical risk factors, waist-to-hip ratio, hypertension, glycemic control, HbA1c, glucose disposal rate, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Body Constitution, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Insulin, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Glucose Clamp Technique, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
